BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25197510)

  • 1. Hepatocellular carcinoma in the world and the middle East.
    Poustchi H; Sepanlou S; Esmaili S; Mehrabi N; Ansarymoghadam A
    Middle East J Dig Dis; 2010 Jan; 2(1):31-41. PubMed ID: 25197510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
    Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E
    World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.
    Alavian SM; Haghbin H
    Hepat Mon; 2016 Mar; 16(3):e35106. PubMed ID: 27226803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Liver Cancer in Africa: Current and Future Trends.
    Okeke E; Davwar PM; Roberts L; Sartorius K; Spearman W; Malu A; Duguru M
    Semin Liver Dis; 2020 May; 40(2):111-123. PubMed ID: 31726474
    [TBL] [Abstract][Full Text] [Related]  

  • 5.  Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries.
    Seyda Seydel G; Kucukoglu O; Altinbasv A; Demir OO; Yilmaz S; Akkiz H; Otan E; Sowa JP; Canbay A
    Ann Hepatol; 2016; 15(5):662-72. PubMed ID: 27493104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma and non-alcoholic fatty liver disease.
    Golabi P; Rhea L; Henry L; Younossi ZM
    Hepatol Int; 2019 Nov; 13(6):688-694. PubMed ID: 31701393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
    Bertot LC; Adams LA
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral hepatitis and hepatocellular carcinoma.
    Michielsen PP; Francque SM; van Dongen JL
    World J Surg Oncol; 2005 May; 3():27. PubMed ID: 15907199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination.
    Vo Quang E; Shimakawa Y; Nahon P
    Liver Int; 2021 May; 41(5):915-927. PubMed ID: 33641230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries.
    Madihi S; Syed H; Lazar F; Zyad A; Benani A
    Biomed Res Int; 2020; 2020():7027169. PubMed ID: 32626758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?
    Amponsah-Dacosta E
    World J Gastroenterol; 2021 Sep; 27(36):6025-6038. PubMed ID: 34629817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in Asia: Prevention strategy and planning.
    Ashtari S; Pourhoseingholi MA; Sharifian A; Zali MR
    World J Hepatol; 2015 Jun; 7(12):1708-17. PubMed ID: 26140091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?
    Smolle E; Zöhrer E; Bettermann K; Haybaeck J
    Hepat Mon; 2012 Oct; 12(10 HCC):e7879. PubMed ID: 23233866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation.
    Gu J; Yao M; Yao D; Wang L; Yang X; Yao D
    J Clin Transl Hepatol; 2016 Jun; 4(2):123-30. PubMed ID: 27350942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatocellular carcinoma--epidemiology and treatment].
    Małkowski P; Pacholczyk M; Łagiewska B; Adadyński L; Wasiak D; Kwiatkowski A; Chmura A; Czerwiński J
    Przegl Epidemiol; 2006; 60(4):731-40. PubMed ID: 17682755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics.
    Flores A; Marrero JA
    Clin Med Insights Oncol; 2014; 8():71-6. PubMed ID: 24899827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma: an Asian perspective.
    Teo EK; Fock KM
    Dig Dis; 2001; 19(4):263-8. PubMed ID: 11935085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.
    Mittal S; Sada YH; El-Serag HB; Kanwal F; Duan Z; Temple S; May SB; Kramer JR; Richardson PA; Davila JA
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):594-601.e1. PubMed ID: 25148760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma: Epidemiology, pathogenesis and surveillance - implications for sub-Saharan Africa.
    Zakharia K; Luther CA; Alsabbak H; Roberts LR
    S Afr Med J; 2018 Aug; 108(8b):35-40. PubMed ID: 30182911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.